| 1. | Modifications of lanosterol into other steroids are classified as steroidogenesis transformations.
|
| 2. | Lanosterol is a key four-ringed intermediate in cholesterol biosynthesis.
|
| 3. | In humans, lanosterol synthase is encoded by the LSS gene.
|
| 4. | Finally, lanosterol is converted to cholesterol through a 19-step process.
|
| 5. | Lanosterol can then be converted into other steroids such as cholesterol and ergosterol.
|
| 6. | Because terbinafine prevents conversion of squalene to lanosterol, ergosterol cannot be synthesized.
|
| 7. | Oxidosqualene cyclase then cyclizes squalene to form lanosterol.
|
| 8. | Lanosterol can then be converted into other steroids, such as cholesterol and ergosterol.
|
| 9. | Incorporation of lanosterol into viridin has been described.
|
| 10. | Lanosterol synthase inhibitors are thought to lower LDL and VLDL cholesterol by a dual control mechanism.
|